309 related articles for article (PubMed ID: 36003616)
1. Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products.
Cheng X; Yan H; Pang S; Ya M; Qiu F; Qin P; Zeng C; Lu Y
Front Chem; 2022; 10():963004. PubMed ID: 36003616
[TBL] [Abstract][Full Text] [Related]
2. Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer.
Kumar Giri T; Giri A; Kumar Barman T; Maity S
Anticancer Agents Med Chem; 2016; 16(7):816-31. PubMed ID: 26567624
[TBL] [Abstract][Full Text] [Related]
3. BODIPY-based fluorescent liposomes with sesquiterpene lactone trilobolide.
Škorpilová L; Rimpelová S; Jurášek M; Buděšínský M; Lokajová J; Effenberg R; Slepička P; Ruml T; Kmoníčková E; Drašar PB; Wimmer Z
Beilstein J Org Chem; 2017; 13():1316-1324. PubMed ID: 28781697
[TBL] [Abstract][Full Text] [Related]
4. Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine.
Sun R; Dai J; Ling M; Yu L; Yu Z; Tang L
J Nanobiotechnology; 2022 Apr; 20(1):194. PubMed ID: 35443712
[TBL] [Abstract][Full Text] [Related]
5. Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes.
Coimbra M; Isacchi B; van Bloois L; Torano JS; Ket A; Wu X; Broere F; Metselaar JM; Rijcken CJ; Storm G; Bilia R; Schiffelers RM
Int J Pharm; 2011 Sep; 416(2):433-42. PubMed ID: 21291975
[TBL] [Abstract][Full Text] [Related]
6. [Advances in the research on targeted preparations of traditional Chinese medicine and natural drugs].
Yang CX; Xu XH; Dong Y
Zhongguo Zhong Yao Za Zhi; 2003 Aug; 28(8):696-700. PubMed ID: 15015344
[TBL] [Abstract][Full Text] [Related]
7. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
Wang Y; Grainger DW
Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
[TBL] [Abstract][Full Text] [Related]
8. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
9. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
[TBL] [Abstract][Full Text] [Related]
10. Liposomal nanostructures for photosensitizer delivery.
Jin CS; Zheng G
Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
12. Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency.
Shigehiro T; Masuda J; Saito S; Khayrani AC; Jinno K; Seno A; Vaidyanath A; Mizutani A; Kasai T; Murakami H; Satoh A; Ito T; Hamada H; Seno Y; Mandai T; Seno M
Nanomaterials (Basel); 2017 Sep; 7(10):. PubMed ID: 28946623
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-coated nano-liposomes for the oral delivery of berberine hydrochloride.
Nguyen TX; Huang L; Liu L; Elamin Abdalla AM; Gauthier M; Yang G
J Mater Chem B; 2014 Nov; 2(41):7149-7159. PubMed ID: 32261793
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging-Guided Multi-Stimulus-Responsive Drug Delivery Strategy for Personalized and Precise Cancer Treatment.
Liu C; Chen H; Zhou H; Yu S; Wang N; Yao W; Lu AH; Qiao W
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50716-50732. PubMed ID: 34668377
[TBL] [Abstract][Full Text] [Related]
15. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.
Liu P; Chen G; Zhang J
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209162
[TBL] [Abstract][Full Text] [Related]
16. Protein-coated and polysaccharide-coated liposomes as drug carriers.
Sunamoto J; Iwamoto K
Crit Rev Ther Drug Carrier Syst; 1986; 2(2):117-36. PubMed ID: 3518958
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
Mamasheva E; O'Donnell C; Bandekar A; Sofou S
Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
Ranade VV
J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
[TBL] [Abstract][Full Text] [Related]
19. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.
Eloy JO; Claro de Souza M; Petrilli R; Barcellos JP; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2014 Nov; 123():345-63. PubMed ID: 25280609
[TBL] [Abstract][Full Text] [Related]
20. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
